endocrinology
Risk factors

Pioglitazone reduces CV risk in insulin resistant

Pioglitazone may reduce the risk of MI and stroke in people who are insulin resistant and have had a recent TIA or stroke, researchers report. Published in the NEJM the study randomised almost 4,000 patients who had a recent TIA or stroke to either pioglitzone (45mg daily) or placebo. Patients included in the study did not ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic